Monte Rosa Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Monte Rosa Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2025.
  • Monte Rosa Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $4.89M, a 8.71% increase year-over-year.
  • Monte Rosa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $18.1M, a 8.74% increase from 2023.
  • Monte Rosa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $16.7M, a 42.9% increase from 2022.
  • Monte Rosa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.7M, a 124% increase from 2021.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $4.89M +$392K +8.71% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $5.3M +$425K +8.72% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q2 2024 $4.5M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $4.87M +$899K +22.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $3.97M +$1.72M +76.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $2.25M +$2M +793% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q2 2021 $1.27M +$1.16M +1077% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $252K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q2 2020 $108K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.